Successfully reported this slideshow.
Your SlideShare is downloading. ×

OS16 - 3.1.b Outbreaks of Foot-and-Mouth Disease Virus in the Middle East During 2015 and 2016 Due to an Exotic A/ASIA/G-VII(G18) Lineage - J. Wadsworth

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 17 Ad
Advertisement

More Related Content

More from EuFMD (20)

Recently uploaded (20)

Advertisement

OS16 - 3.1.b Outbreaks of Foot-and-Mouth Disease Virus in the Middle East During 2015 and 2016 Due to an Exotic A/ASIA/G-VII(G18) Lineage - J. Wadsworth

  1. 1. OS16 FMD Reference Laboratory OUTBREAKS OF FOOT-AND-MOUTH DISEASE VIRUS IN THE MIDDLE EAST DURING 2015 AND 2016 DUE TO AN EXOTIC A/ASIA/G-VII (G-18) LINEAGE Jemma Wadsworth, Katarzyna Bachanek-Bankowska, Barsha Thapa, Donald P. King and Nick J. Knowles
  2. 2. OS16 FMDV A in Asia: 2005-2015
  3. 3. OS16
  4. 4. OS16
  5. 5. OS16
  6. 6. OS16 FMDV A Genotype VII (18) • Iran, August to December 2015 (Qom province) • Traced to Miyandoab live animal market in West Azerbaijan province. • Saudi Arabia, September 2015 (4 farms) • Turkey, September to October 2015 (Van, Bitlis & Amasya provinces) – 217 + outbreaks • Armenia, December 2015
  7. 7. OS16 Sequence analysis A/SAU/2/2015 A/SAU/6/2015 A/SAU/1/2015 (KU127247) A/SAU/3/2015 A/SAU/4/2015 A/PD78/IND/2015* (PD-FMD) A/SAU/5/2015 A/ARM/2/2015 (ARRIAH) A/IRN/12/2015 A/Van/TUR/203/2015* (FMDI) A/IRN/8/2015 A/ARM/1/2015 (ARRIAH) A/ARM/3/2015 (ARRIAH) 99 99 99 A/SAU/2/2015 A/SAU/6/2015 A/SAU/1/2015 (KU127247) A/SAU/3/2015 A/SAU/4/2015 A/PD78/IND/2015* (PD-FMD) A/SAU/5/2015 A/ARM/2/2015 (ARRIAH) A/IRN/12/2015 A/Van/TUR/203/2015* (FMDI) A/IRN/8/2015 A/ARM/1/2015 (ARRIAH) A/ARM/3/2015 (ARRIAH) A/BAN/GA/Sa-197/2013 (KJ754939) A/IND/256/2012(582)* (PD-FMD) A/IND/84/2011(202)* (PD-FMD) A/IND/113/2012(213)* (PD-FMD) A/IND/413/2007* (HQ127707) A/IND/417/2007* (HQ127708) A/IND/360/2007* (HQ127705) A/IND/245/2007* (HQ832590) A/IND/360/07* (FJ617243) A/IND/245/2007* (HQ127704) A/IND/9/2009* (2008) (HQ127716) A/IND/17/2009* (2008) (HQ127719) A/IND/11/2009* (2008) (HQ127717) A/IND/17/2009* (HQ832592) A/IND/64/2004* (HQ127678) A/IND/64/2004* (HQ832581) A/BHU/4/2003 A/BHU/40/2003 A/IND/281/2003* (HQ832579) A/IND/249/2004* (HQ127680) A/IND/249/2004* (HQ832582) A/IND/243/04* (FJ617245) A/IND/818/03* (FJ617249) A/IND/818/2003* (HQ832580) A/IND/161/2003* (HQ832578) A/BHU/27/2003 (FJ755013) A/BHU/42/2003 A/IND/820/03* (FJ617251) A/IND/447/2005* (HQ832583) A/IND/447/2005* (HQ127685) A/BHU/6/2003 A/BHU/7/2003 (FJ755012) A/BHU/41/2002 (EU414525) A/BHU/8/2003 A/BHU/35/2003 A/SAU/16/95 (EU553874) A/IND/40/2000* (1999AF390646) A/IND/154/2013(333)* (PD-FMD) G-VII (G-18) 99 99 99 77 85 99 90 99 96 99 77 96 74 88 99 99 78 99 98 94 86 99 71 72
  8. 8. OS16 Years 1973 1976 1984 1986-87 1991-1995 2005 2015 A/IRN/1/2011 A/IRN/15/2012 A/IRN/78/2009 A/AFG/10/2010 A/AFG/6/2007 (FJ755007) A/IRN/125/2010 A/BAR/6/2008 (FJ755010) A/TUR/1/2008 (FJ755133) A/TUR/3/2010 A/IRN/1/2005 (EF208769) A/TUR/33/2008 (FJ755155) A/SAU/15/2005 (FJ755086) A/SAU/16/2005 (FJ755087) A/IRN/9/2010 A/IRN/9/2011 Iran-05 Iran-99A/IRN/22/99 (EF208772) A/IRN/2/87 (EF208770) A/SAU/41/91 (FJ755085) Iran-87 Thai-87A/TAI/118/87* (EF208777) A/TAI/7/2003 (HQ116312) A/TAI/2/97 (EF208778) Sea-97 A22A22/IRQ/64 (AY593763) Iran-96A/IRN/1/96 (EF208771) A/SAU/23/86 (EU414536) A/SAU/1/2015 A/SAU/2/2015 A/Van/203/TUR/2015 A/BAN/GA/Sa-197/2013 (KJ754939) A/BAN/BD/SI/16/2013 (KR869773) A/IND/256/98* (AF390628) A/SAU/16/95 (EU553874) A/ALB/1/96 (EU553850) A/MCD/1/96 (EU553869) A/IND/270/96* (AF390631) A/IND/287/96* (AF390633) A15A15/Bangkok/TAI/60 (AY593755) ASIA EURO-SA AFRICA 100 100 93 98 100 100 86 98 100 77 99 99 99 99 72 98 100 80 100 0.02 Historical context Saudi Arabia FMDV type A
  9. 9. OS16 Reference viruses Field viruses Site 3 Site 1 1043-1047 1138-1154 A/ERI/3/98 NSPTP TSVSPRRGDLGALAARV A22/IRQ/24/64 QNLNP AGGTGRRGDLGPLAARV A/MAY/97 KPVSP TPGA-RRGDLGSLAARD A/IRN/31/2005 SPVSP TTGNGRRGDLGPLAARV A/TUR/4/2006 SPVSP TTGNGRRGDLGSLAARV A/IRN/12/2015 VNVSP AASGRARGDLGQLAARV A/Van/TUR/203/2015 VNVSP AASGRARGDLGQLAARV A/SAU/1/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/2/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/6/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/3/2015 VNVSP AASGRARGDTGQLAARV A/SAU/4/2015 VNVSP AASGRARGDTGQLAARV A/SAU/5/2015 VNVSP AASGRARGDLEQLTARV A/SAU/7/2015 VNVSP AASGRARGDLEQLTARV A/SAU/8/2015 VNVSP TASGRARGDLEQLTARV A/SAU/15/2016 VNVSP AASGRARGDLEQLTARV
  10. 10. OS16 Reference viruses Field viruses Site 3 Site 1 1043-1047 1138-1154 A/ERI/3/98 NSPTP TSVSPRRGDLGALAARV A22/IRQ/24/64 QNLNP AGGTGRRGDLGPLAARV A/MAY/97 KPVSP TPGA-RRGDLGSLAARD A/IRN/31/2005 SPVSP TTGNGRRGDLGPLAARV A/TUR/4/2006 SPVSP TTGNGRRGDLGSLAARV A/IRN/12/2015 VNVSP AASGRARGDLGQLAARV A/Van/TUR/203/2015 VNVSP AASGRARGDLGQLAARV A/SAU/1/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/2/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/6/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/3/2015 VNVSP AASGRARGDTGQLAARV A/SAU/4/2015 VNVSP AASGRARGDTGQLAARV A/SAU/5/2015 VNVSP AASGRARGDLEQLTARV A/SAU/7/2015 VNVSP AASGRARGDLEQLTARV A/SAU/8/2015 VNVSP TASGRARGDLEQLTARV A/SAU/15/2016 VNVSP AASGRARGDLEQLTARV Farm 1
  11. 11. OS16 Reference viruses Field viruses Site 3 Site 1 1043-1047 1138-1154 A/ERI/3/98 NSPTP TSVSPRRGDLGALAARV A22/IRQ/24/64 QNLNP AGGTGRRGDLGPLAARV A/MAY/97 KPVSP TPGA-RRGDLGSLAARD A/IRN/31/2005 SPVSP TTGNGRRGDLGPLAARV A/TUR/4/2006 SPVSP TTGNGRRGDLGSLAARV A/IRN/12/2015 VNVSP AASGRARGDLGQLAARV A/Van/TUR/203/2015 VNVSP AASGRARGDLGQLAARV A/SAU/1/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/2/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/6/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/3/2015 VNVSP AASGRARGDTGQLAARV A/SAU/4/2015 VNVSP AASGRARGDTGQLAARV A/SAU/5/2015 VNVSP AASGRARGDLEQLTARV A/SAU/7/2015 VNVSP AASGRARGDLEQLTARV A/SAU/8/2015 VNVSP TASGRARGDLEQLTARV A/SAU/15/2016 VNVSP AASGRARGDLEQLTARV Farm 2
  12. 12. OS16 Reference viruses Field viruses Site 3 Site 1 1043-1047 1138-1154 A/ERI/3/98 NSPTP TSVSPRRGDLGALAARV A22/IRQ/24/64 QNLNP AGGTGRRGDLGPLAARV A/MAY/97 KPVSP TPGA-RRGDLGSLAARD A/IRN/31/2005 SPVSP TTGNGRRGDLGPLAARV A/TUR/4/2006 SPVSP TTGNGRRGDLGSLAARV A/IRN/12/2015 VNVSP AASGRARGDLGQLAARV A/Van/TUR/203/2015 VNVSP AASGRARGDLGQLAARV A/SAU/1/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/2/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/6/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/3/2015 VNVSP AASGRARGDTGQLAARV A/SAU/4/2015 VNVSP AASGRARGDTGQLAARV A/SAU/5/2015 VNVSP AASGRARGDLEQLTARV A/SAU/7/2015 VNVSP AASGRARGDLEQLTARV A/SAU/8/2015 VNVSP TASGRARGDLEQLTARV A/SAU/15/2016 VNVSP AASGRARGDLEQLTARV Farm 3
  13. 13. OS16 Reference viruses Field viruses Site 3 Site 1 1043-1047 1138-1154 A/ERI/3/98 NSPTP TSVSPRRGDLGALAARV A22/IRQ/24/64 QNLNP AGGTGRRGDLGPLAARV A/MAY/97 KPVSP TPGA-RRGDLGSLAARD A/IRN/31/2005 SPVSP TTGNGRRGDLGPLAARV A/TUR/4/2006 SPVSP TTGNGRRGDLGSLAARV A/IRN/12/2015 VNVSP AASGRARGDLGQLAARV A/Van/TUR/203/2015 VNVSP AASGRARGDLGQLAARV A/SAU/1/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/2/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/6/2015 VNVSP AASGRTRGDQGQLAARV A/SAU/3/2015 VNVSP AASGRARGDTGQLAARV A/SAU/4/2015 VNVSP AASGRARGDTGQLAARV A/SAU/5/2015 VNVSP AASGRARGDLEQLTARV A/SAU/7/2015 VNVSP AASGRARGDLEQLTARV A/SAU/8/2015 VNVSP TASGRARGDLEQLTARV A/SAU/15/2016 VNVSP AASGRARGDLEQLTARV Farm 4
  14. 14. OS16 Saudi Arabia and A G-VII Outbreaks have been reported on large scale dairy farms, confirmed as serotype A G-VII Farms using regular vaccination with aqueous based, NSP purified, ≥6.0PD50 vaccine Contains A Iran 05 and A Saudi 95 strains as part of a polyvalent vaccine Vaccination schedule – Primary course 3, 4, 5 and 6 months of age – Booster every 90 days thereafter
  15. 15. OS16 A/SAU/1/2015 A/SAU/2/2015 A/IRN/8/2015 A/IRN/12/2015 A-Iran-05 0 0 0.03 0 A-Iran-87 0 0.04 nd nd A-Iran-96 0.04 0.06 nd nd A-Iran-99 0.01 0.01 nd nd A-Sau-95* 0.11 0.12 0.19 0.11 A-22 0.11 0.11 0.13 0.04 A-Tur-20-06 0.03 0.06 0.01 0.15 A-May-97 0.14 0.23 0.23 0.15 A-Tur-11 0.01 nd 0.10 0.04 A-Tur-14 0 nd 0 0 A-IND-40-2000* 0.26 nd 0.03 0.24 Recent r-values: * Multiple BVS tested Poor in-vitro match to many commercial vaccines FAR-11A/IRN/1/2011 SIS-12A/IRN/15/2012 FAR-09A/IRN/78/2009 HER-10A/AFG/10/2010 AFG-07A/AFG/6/2007 (FJ755007) SIS-10A/IRN/125/2010 BAR-08A/BAR/6/2008 (FJ755010) ARD-07A/TUR/1/2008 (FJ755133) KSS-09A/TUR/3/2010 A/IRN/1/2005 (EF208769) EZM-07A/TUR/33/2008 (FJ755155) A/SAU/15/2005 (FJ755086) A/SAU/16/2005 (FJ755087) ESF-10A/IRN/9/2010 QAZ-11A/IRN/9/2011 Iran-05 Iran-99A/IRN/22/99 (EF208772) A/IRN/2/87 (EF208770) A/SAU/41/91 (FJ755085) Iran-87 Thai-87A/TAI/118/87* (EF208777) A/TAI/7/2003 (HQ116312) A/TAI/2/97 (EF208778) Sea-97 A22A22/IRQ/64 (AY593763) Iran-96A/IRN/1/96 (EF208771) Saudi-86A/SAU/23/86 (EU414536) A/IRN/8/2015 A/IRN/12/2015 A/SAU/1/2015 (KU127247) A/SAU/2/2015 A/BAN/GA/Sa-197/2013 (KJ754939) A/BAN/BD/SI/16/2013 (KR869773) A/IND/40/2000* (1999AF390646) A/IND/256/98* (AF390628) A/SAU/16/95 (EU553874) A/ALB/1/96 (EU553850) A/MCD/1/96 (EU553869) A/IND/270/96* (AF390631) A/IND/287/96* (AF390633) G-VII (G-14) A15A15/Bangkok/TAI/60 (AY593755) ASIA EURO-SA AFRICA 99 100 75 100 93 99 100 72 99 91 84 100 99 99 99 98 99 81 100 0.02 Current vaccines Saudi viruses
  16. 16. OS16 • Rapidly changing situation – very dynamic • Collection of samples from field outbreaks is vital • Important to continue to exchange epidemiological data and laboratory results • Vaccine recommendations require careful consideration • Apparent gap in vaccine coverage • WRLFMD is collating lab and field data regarding the performance of vaccine against this strain • Greater confidence in the use of vaccines urgently required – from in vivo potency tests or data from the field (vaccine efficacy). Summary and priorities
  17. 17. OS16 • Fuat Özyörük, Alexei Mischenko, Alexei Scherbakov, Jitendra Biswal and Bramhadev Pattnaik, for providing sequence data. • Support for the WRLFMD and research projects • Collaborating FMD Reference Laboratories and field teams • Partners within the OIE/FAO FMD Lab Network • Funding by DEFRA Acknowledgements WRLFMD Team: Don King, Valerie Mioulet, Nick Knowles, Anna Ludi, Ginette Wilsden, Kasia Bachanek-Bankowska, Lissie Henry, Britta Wood, Barsha Thapa, Bob Statham, Abid Bin-Tarif, Ashley Gray, Clare Browning, Beth Johns, Mark Henstock, Alison Morris, David Paton, Nick Lyons, Dexter Wiseman, Julie Maryan, Sarah Belgrave

×